Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2016 · 10-Q
Revenue$140.44M$140.44M+5.9% vs Q2 2015 Net Income$1.87M$1.87M−42.0% vs Q2 2015 EPS Diluted$0.07$0.07−41.7% vs Q2 2015 Gross Profit$17,265,000+10.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,047,000N/M Free Cash Flowderived-$7,669,000— Margins · derivedGross margin12.3%+0.5 pt vs Q2 2015
Operating margin2.0%−0.9 pt vs Q2 2015
Net margin1.3%−1.1 pt vs Q2 2015
ended Nov 29, 2015 · filed Jan 7, 2016 · 39 d after period end